Press release
Viral Hepatitis Market Forecast 2025-2034: Analysing Major Trends, Opportunities, and Growth Drivers
Viral Hepatitis Market
The burgeoning incidence of hepatitis is predicted to fuel the expansion of the viral hepatitis market. Hepatitis, a liver infection caused by various infectious and non-infectious elements, can induce numerous health complications. Viral hepatitis, in particular, resulting from Hepatitis A, B, C, D, and E causes inflammation and damage to the liver. For instance, the European Centre for Disease Prevention and Control reported in April 2024 that there were 28,855 documented instances of hepatitis B virus (HBV) infection across 30 EU/EEA Member States in 2022, a 78% rise compared to 16,187 cases in 2021. The cases in 2022, which totaled to 28,420, indicates a crude rate of 8.5 cases per 100,000 individuals. Therefore, the growing incidence of hepatitis is likely to boost the viral hepatitis market. Market Driver for Viral Hepatitis: Augmentation in Research and Development Activities Propels Viral Hepatitis Market Growth
Get Your Viral Hepatitis Market Report Here:
https://www.thebusinessresearchcompany.com/report/viral-hepatitis-global-market-report
What is the projected compound annual growth rate (CAGR) of the viral hepatitis market from 2025 to 2034, and what factors influence it?
The market size for viral hepatitis has experienced consistent growth over the recent years. A rise from $16.21 billion in 2024 to $16.93 billion in 2025 is predicted, exhibiting a compound annual growth rate (CAGR) of 4.4%. Factors contributing to the growth during the historic period are the creation of vaccines, blood screening initiatives, antiviral medications, and international health campaigns.
The market size of viral hepatitis is anticipated to progressively grow in the forthcoming years. A compound annual growth rate (CAGR) of 4.2% will take it to a $19.97 billion valuation by 2029. The growth during the predicted period can be credited to factors such as the availability of treatment, public health laws, combination therapies, and initiatives focused on health equity. Noteworthy trends to be observed in this period comprise personalized treatment strategies, digital healthcare resources, applications of AI in monitoring diseases, along with micro-elimination of Hepatitis C.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13028&type=smp
How are the latest trends influencing the growth of the viral hepatitis market?
In an effort to maintain their position within the viral hepatitis market, businesses are focusing on the development and advancement of new drugs. Such innovation and development enhance scientific knowledge by providing a deeper understanding of disease mechanisms and fast-tracking the creation of new treatments. For example, Gilead Sciences Inc., a biopharmaceutical corporation based in the US, declared in November 2022 that the FDA had given its supplemental new medicine application (sNDA) for Vemlidy (tenofovir alafenamide) 25 mg tablets. This treatment, meant to be taken once a day, has been approved for the treatment of chronic hepatitis B virus (HBV) infection in children twelve years old and older suffering from compensated liver disease. The endorsement of Vemlidy for this group of pediatric patients was supported by results from a 24-week phase 2 clinical trial.
What are the major segments of the viral hepatitis market and their role in driving growth?
The viral hepatitis market covered in this report is segmented -
1) By Disease Type: Hepatitis A, Hepatitis B, Hepatitis C, Other Disease Types
2) By Diagnosis: Liver Biopsy, Blood Tests, Imaging Tests, Other Diagnosis
3) By Treatment: Antiviral Drugs, Surgery, Vaccine, Immune Modulator Drugs, Other Treatments
4) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration
5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users
Subsegments:
1) By Hepatitis A: Acute Hepatitis A, Chronic Hepatitis A
2) By Hepatitis B: Acute Hepatitis B, Chronic Hepatitis B, Hepatitis B Carrier
3) By Hepatitis C: Acute Hepatitis C, Chronic Hepatitis C
4) By Other Disease Types: Hepatitis D, Hepatitis E
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13028
North America was the largest region in the viral hepatitis market in 2024. The regions covered in viral hepatitis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Who are the key firms paving the way for growth in the viral hepatitis market?
Major companies operating in the viral hepatitis market are Pfizer Inc., Johnson & Johnson Co, F Hoffmann-La Roche AG, Merck & Co., AbbVie Inc., Novartis AG, Sanofi SA, Bristol-Myers Squibb, Astra Zeneca Pharmaceuticals LP, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Daiichi Sankyo Co. Ltd., Hetero Drugs Ltd., Eisai Co. Ltd., Boehringer Ingelheim Group, Sun Pharmaceutical Industries Ltd., Lupin Limited, Dr. Reddy's Laboratories, Zydus Lifescience Ltd., Glenmark Pharmaceuticals Ltd., Cipla Ltd., Torrent Pharmaceuticals Ltd., Otsuka Pharmaceutical Co. Ltd., Wockhardt Ltd.
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=13028&type=smp
What Is Covered In The Viral Hepatitis Global Market Report?
•Market Size Forecast: Examine the viral hepatitis market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the viral hepatitis market for a structured understanding.
•Key Players Overview: Analyze major players in the viral hepatitis market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the viral hepatitis market.
•Segment Contributions: Evaluate how different segments drive overall growth in the viral hepatitis market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the viral hepatitis market.
•Industry Challenges: Identify potential risks and obstacles affecting the viral hepatitis market.
•Competitive Landscape: Review strategic developments in the viral hepatitis market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Viral Hepatitis Market Forecast 2025-2034: Analysing Major Trends, Opportunities, and Growth Drivers here
News-ID: 3920028 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Hepatitis
POC Diagnostics Encourages Timely Hepatitis Testing Amid WHO's Hepatitis D Carci …
Birmingham, 18th September, 2025:
The World Health Organization (WHO) recently classified Hepatitis D as a carcinogen and raised a global concern about its link to liver cancer. In response to this, POC Diagnostic, one of the renowned and leading providers of modern medical testing solutions, urges both individuals and healthcare providers to prioritise early Hepatitis recognition.
Timely detection of Hepatitis infections is critical to prevent severe health complications. POC Diagnostics is…
Driving Viral Hepatitis Market Growth in 2025: The Role of Elevated Prevalence O …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts
Viral Hepatitis Market Size Growth Forecast: What to Expect by 2025?
In the past few years, the size of the viral hepatitis market has experienced consistent growth. It is projected to increase from $16.21 billion in 2024 to $16.93 billion in 2025, representing a compound annual growth rate (CAGR)…
Elevated Prevalence Of Hepatitis Driving Growth In The Viral Hepatitis Market: A …
The Viral Hepatitis Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Viral Hepatitis Market Size and Its Estimated Growth Rate?
In the past few years, there has been a consistent increase in the size of the viral hepatitis market. It is predicted…
Elevated Prevalence Of Hepatitis Driving Growth In The Viral Hepatitis Market: A …
The Viral Hepatitis Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Viral Hepatitis Market Size and Its Estimated Growth Rate?
In the past few years, there has been a consistent increase in the size of the viral hepatitis market. It is predicted…
Hepatitis D Market - Defeating Hepatitis D Together: Uniting Against the Silent …
Newark, New Castle, USA - The latest report from Growth Plus Reports analyzes the production, potential applications, demand, major manufacturers, and SWOT analysis of the global Hepatitis D Market.
Hepatitis D Market: https://www.growthplusreports.com/report/hepatitis-d-market/9196
The Hepatitis D Market Report assists in determining the optimum distribution methods for certain products as well as possible markets for future product launches. The report also analyses the purchase and supply trends that influence the market's production strategy.…
Hepatitis C Testing Market - Advancing Hepatitis C Elimination Strategies: Embra …
Newark, New Castle, USA: The "Hepatitis C Testing Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Hepatitis C Testing Market: https://www.growthplusreports.com/report/hepatitis-c-testing-market/7962
This latest report researches the industry structure,…
